155 related articles for article (PubMed ID: 32946960)
1. Topical ocular pharmacokinetics and bioavailability for a cocktail of atenolol, timolol and betaxolol in rabbits.
Fayyaz A; Ranta VP; Toropainen E; Vellonen KS; Valtari A; Puranen J; Ruponen M; Gardner I; Urtti A; Jamei M; Del Amo EM
Eur J Pharm Sci; 2020 Dec; 155():105553. PubMed ID: 32946960
[TBL] [Abstract][Full Text] [Related]
2. Ocular pharmacokinetics of atenolol, timolol and betaxolol cocktail: Tissue exposures in the rabbit eye.
Fayyaz A; Vellonen KS; Ranta VP; Toropainen E; Reinisalo M; Valtari A; Puranen J; Ricci GD; Heikkinen EM; Gardner I; Ruponen M; Urtti A; Jamei M; Del Amo EM
Eur J Pharm Biopharm; 2021 Sep; 166():155-162. PubMed ID: 34139290
[TBL] [Abstract][Full Text] [Related]
3. Ocular Intracameral Pharmacokinetics for a Cocktail of Timolol, Betaxolol, and Atenolol in Rabbits.
Fayyaz A; Ranta VP; Toropainen E; Vellonen KS; Ricci GD; Reinisalo M; Heikkinen EM; Gardner I; Urtti A; Jamei M; Del Amo EM
Mol Pharm; 2020 Feb; 17(2):588-594. PubMed ID: 31794668
[TBL] [Abstract][Full Text] [Related]
4. Systemic absorption pathways of topically applied beta adrenergic antagonists in the pigmented rabbit.
Lee YH; Kompella UB; Lee VH
Exp Eye Res; 1993 Sep; 57(3):341-9. PubMed ID: 7901046
[TBL] [Abstract][Full Text] [Related]
5. Short-term effect of beta-adrenoreceptor blocking agents on ocular blood flow.
Sato T; Muto T; Ishibashi Y; Roy S
Curr Eye Res; 2001 Oct; 23(4):298-306. PubMed ID: 11852432
[TBL] [Abstract][Full Text] [Related]
6. Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.
Brooks AM; Gillies WE
Drugs Aging; 1992; 2(3):208-21. PubMed ID: 1351412
[TBL] [Abstract][Full Text] [Related]
7. Optic nerve vasomotor effects of topical beta-adrenergic antagonists in rabbits.
Orgül S; Mansberger S; Bacon DR; Van Buskirk EM; Cioffi GA
Am J Ophthalmol; 1995 Oct; 120(4):441-7. PubMed ID: 7573301
[TBL] [Abstract][Full Text] [Related]
8. Formulation influence on conjunctival penetration of four beta blockers in the pigmented rabbit: a comparison with corneal penetration.
Ashton P; Podder SK; Lee VH
Pharm Res; 1991 Sep; 8(9):1166-74. PubMed ID: 1788163
[TBL] [Abstract][Full Text] [Related]
9. Plasma and aqueous humour concentrations and systemic effects of topical betaxolol and timolol in man.
Vuori ML; Ali-Melkkilä T; Kaila T; Iisalo E; Saari KM
Acta Ophthalmol (Copenh); 1993 Apr; 71(2):201-6. PubMed ID: 8333266
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and intraocular pressure lowering effect of timolol preparations in rabbit eyes.
Chiang CH; Ho JI; Chen JL
J Ocul Pharmacol Ther; 1996; 12(4):471-80. PubMed ID: 8951683
[TBL] [Abstract][Full Text] [Related]
11. An in vitro approach to investigate ocular metabolism of a topical, selective β1-adrenergic blocking agent, betaxolol.
Bushee JL; Dunne CE; Argikar UA
Xenobiotica; 2015 May; 45(5):396-405. PubMed ID: 25475994
[TBL] [Abstract][Full Text] [Related]
12. Ocular drug delivery using 20-kHz ultrasound.
Zderic V; Vaezy S; Martin RW; Clark JI
Ultrasound Med Biol; 2002 Jun; 28(6):823-9. PubMed ID: 12113795
[TBL] [Abstract][Full Text] [Related]
13. Topical pharmacokinetics of dexamethasone suspensions in the rabbit eye: Bioavailability comparison.
Naageshwaran V; Ranta VP; Toropainen E; Tuomainen M; Gum G; Xie E; Bhoopathy S; Urtti A; Del Amo EM
Int J Pharm; 2022 Mar; 615():121515. PubMed ID: 35091006
[TBL] [Abstract][Full Text] [Related]
14. Tolerability of timolol and betaxolol in patients with chronic open-angle glaucoma.
Kendall K; Mundorf T; Nardin G; Zimmerman TJ; Hesse R; Lavin P
Clin Ther; 1987; 9(6):651-5. PubMed ID: 2894245
[TBL] [Abstract][Full Text] [Related]
15. Ophthalmic beta-blockers: determination of plasma and aqueous humor levels by a radioreceptor assay following multiple doses.
Phan TM; Nguyen KP; Giacomini JC; Lee DA
J Ocul Pharmacol; 1991; 7(3):243-52. PubMed ID: 1686051
[TBL] [Abstract][Full Text] [Related]
16. The favorable effect of topical betaxolol and timolol on glaucomatous visual fields: a 2-year follow-up study.
Vainio-Jylhä E; Vuori ML
Graefes Arch Clin Exp Ophthalmol; 1999 Feb; 237(2):100-4. PubMed ID: 9987624
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of timolol in aqueous humor sampled by microdialysis after topical administration of thermosetting gels.
Wei G; Ding PT; Zheng JM; Lu WY
Biomed Chromatogr; 2006 Jan; 20(1):67-71. PubMed ID: 15954162
[TBL] [Abstract][Full Text] [Related]
18. The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case.
Battistini FD; Tártara LI; Boiero C; Guzmán ML; Luciani-Giaccobbe LC; Palma SD; Allemandi DA; Manzo RH; Olivera ME
Eur J Pharm Sci; 2017 Jul; 105():188-194. PubMed ID: 28506871
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability of timolol and aceclidine after ocular instillation in the rabbit.
Matera MG; Lampa E; Imperatore A; Berrino L; Russo F; Boldrini E; Rossi F
Res Commun Mol Pathol Pharmacol; 1998 Apr; 100(1):35-42. PubMed ID: 9644717
[TBL] [Abstract][Full Text] [Related]
20. The effect of betaxolol and timolol on postoperative intraocular pressure.
Vuori ML; Ali-Melkkilä T
Acta Ophthalmol (Copenh); 1993 Aug; 71(4):458-62. PubMed ID: 8249574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
